The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017
figureposted on 07.12.2017, 14:14 by Andrew Selby
The strongest risk factor for oesophageal adenocarcinoma (OAC) is reflux disease, and the rising incidence coincides with the eradication of Helicobacter pylori, both of which may alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett’s carcinogenesis and investigate the Cytosponge™ as a minimally invasive tool for sampling the oesophageal microbiota.
Dr Robert Brierley, Dr Heather Van Epps
- The Arts, English and Drama